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We have recognized for many years that
environmental agents can modify the course
of respiratory viral infections, and ambient
levels of these agents have been proposed to
play a role in modulating disease severity and
health outcome in exposed individuals. Early
studies that investigated this relationship
demonstrated that the interactive effect
depended on both the infective agent used
and the nature and extent of environmental
exposure. Several of these studies made the
observation that exposure of animals and
human subjects to oxidant pollutants
increased viral infective potential as well as
the magnitude of the resulting virus infec-
tion (1–3). As recent evidence continues to
support the hypothesis that viral infections
can trigger exacerbations of asthma (4–6),
renewed interest has developed in the modu-
lating effect that environmental pollutants
can have on the infective process and on the
severity of resulting disease symptoms.
In their unique location at the interface
between the air space and the submucosal
regions, the epithelial cells of the upper and
lower respiratory tract serve as common tar-
gets for airborne pollutants and several viral
pathogens, including the rhinoviruses (7–9).
A pathophysiologic consequence shared by
rhinovirus infection and exposure to oxidant
pollutants is an inflammatory response
involving the inﬂux of neutrophils and other
cells into the airway tissues and air spaces.
Although the mechanisms through which an
upper respiratory infection might mediate
lower airway inﬂammatory processes are cur-
rently unresolved, the potential importance
of this inﬂammation in the precipitation of
asthmatic episodes remains a focus of great
interest (10,11). Respiratory tract inﬂamma-
tion is mediated largely by the release of
proinflammatory mediators from epithelial
cells (12,13) and is often linked to oxidant-
responsive pathways (14,15). Interactions
between biologic and chemical stimuli that
may share activation pathways have been
well established in a variety of cell types and
can be either additive or synergistic in
nature. These include tumor necrosis factor
α (TNFα), interleukin 1 (IL-1), interferon γ
(IFNγ), phorbol ester, calcium ionophore,
and respiratory syncytial virus (16–19), all of
which can activate “oxidant-sensitive” tran-
scription factors. Despite its implications for
contributing to asthma disease severity,
essentially nothing is known about the
extent to which rhinovirus-induced inflam-
mation can be modified by the exposure of
infected airway epithelium to the commonly
encountered oxidant pollutants nitrogen
dioxide (NO2) and ozone (O3).
We undertook the present study to
investigate the interactive effects of human
rhinovirus type 16 (RV16) and the oxidants
NO2 and O3 on markers of proinflamma-
tory activity in human bronchial and nasal
epithelial cells. Our results demonstrate that
the expression and release of IL-8 and the
surface expression of intercellular adhesion
molecule 1 (ICAM-1) by infected airway
epithelial cells are markedly increased by sub-
sequent exposure of the cells to either of the
pollutant gases at moderate ambient levels.
These results provide evidence for a mecha-
nism through which environmental oxidant
pollutants may exacerbate the pathology of
respiratory viral infections in vivo.
Materials and Methods
Cell culture. We obtained cells of the
BEAS-2B line from the American Type
Culture Collection (ATCC; Bethesda, MD)
and used them below passage 45. We
expanded cultures by growing them on 100-
mm plastic dishes in Ham’s F-12 medium
(Biofluids, Rockville, MD) containing
insulin (5 µg/mL), hydrocortisone (7.2
ng/mL), epidermal growth factor (12.5
ng/mL), endothelial cell growth supplement
(3.75 µg/mL; Gibco, Gaithersburg, MD);
triiodothyronine (6.5 ng/mL), cholera toxin
(10 ng/mL; Sigma, St. Louis, MO), gluta-
mine (2 mM), retinoic acid (0.1 ng/mL),
trace elements (30 nM NaSeO3, 1 nM
MnCl2 • 4H2O, 0.5 µM Na2SiO3 • 9H2O,
1 nM (NH4)6Mo7O24 • 4H2O, 5 nM
NH4VO3, 1 nM NiSO4 • 6H2O, 0.5 nM
SnCl2 • 2H2O), penicillin (100 U/mL),
streptomycin (100 µg/mL), fungizone (0.25
µg/mL; Bioﬂuids). We passaged cells to 24-
well Falcon filter inserts (0.4 µm pore size;
Becton Dickinson, Franklin Lakes, NJ)
coated with Vitrogen 100 (1:3 in 60%
ethanol; Celtrix, Palo Alto, CA) and grew
them to confluence with the same medium
above and below. When the cultures became
conﬂuent, we increased the concentration of
Ca2+ in the medium above and below the
cells to 1.2 mM for at least 18 hr. We
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Of the several factors believed to exacerbate asthmatic symptoms, air pollution and viral infec-
tions are considered to be particularly important. Although evidence indicates that each of these
respiratory insults individually can increase asthma severity in susceptible individuals, we know
little about the extent to which exposure to environmental oxidant pollutants can inﬂuence the
course of respiratory viral infection and its associated inﬂammation. To investigate the interaction
of these two stimuli within their common epithelial cell targets in the upper and lower respiratory
tracks, we infected primary human nasal epithelial cells and cells of the BEAS-2B line grown at
the air–liquid interface with human rhinovirus type 16 (RV16) and exposed them to NO2 (2.0
ppm) or O3 (0.2 ppm) for 3 hr. Independently, RV16, NO2, and O3 rapidly increased release of
the inﬂammatory cytokine interleukin-8 through oxidant-dependent mechanisms. The combined
effect of RV16 and oxidant ranged from 42% to 250% greater than additive for NO2 and from
41% to 67% for O3. We abrogated these effects by treating the cells with the antioxidant N-
acetylcysteine. Surface expression of intercellular adhesion molecule 1 (ICAM-1) underwent addi-
tive enhancement in response to combined stimulation. These data indicate that oxidant
pollutants can amplify the generation of proinﬂammatory cytokines by RV16-infected cells and
suggest that virus-induced inﬂammation in upper and lower airways may be exacerbated by con-
current exposure to ambient levels of oxidants commonly encountered the indoor and outdoor
environments. Key words: bronchial epithelium, ICAM-1, IL-8, nasal epithelium, nitrogen diox-
ide, oxidant stress, ozone. Environ Health Perspect 110:665–670 (2002). [Online 28 May 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p665-670spannhake/abstract.htmlremoved medium from the apical surfaces
1–4 days before study.
Consistent with procedures approved by
the Committee on Human Research of The
Johns Hopkins Bloomberg School of
Hygiene and Public Health, we obtained
chilled nasal tissues removed from patients
undergoing elective ethmoidectomy for
chronic rhinosinusitis within 2 hr of removal.
Tissues selected for use were not polypoid,
infected, or abnormal by gross inspection.
We isolated human nasal epithelial (HNE)
cells after typical procedures. After overnight
digestion of the tissues at 4°C in 0.1% pro-
tease in Ham’s F-12 medium containing
penicillin (100 U/mL), streptomycin (100
µg/mL), fungizone (2.5 µg/mL), and gen-
tamicin (50 µg/mL), we added 10% fetal calf
serum to neutralize the protease and freed the
epithelial cells from the tissue by agitation
and isolated them by centrifugation. We then
seeded the washed cells at a density of ≥ 1.6
× 104 cells/cm2 onto collagen-coated dishes
in Ham’s F-12 medium containing insulin (5
µg/mL), hydrocortisone (0.5 µg/mL), epider-
mal growth factor (0.5 ng/mL), triiodothyro-
nine (6.5 ng/mL), retinoic acid (0.1 ng/mL),
transferrin (10 µg/mL; Gibco), gentamicin
(50 µg/mL), and amphotericin B (50 ng/mL;
Gibco). When they reached confluence, we
transferred the nasal epithelial cells to
Vitrogen-coated 24-well Falcon ﬁlter inserts
(0.4 µm pore size) and grew them to conﬂu-
ence with Dulbecco’s modified Eagle’s
medium:LHC basal medium (50:50;
Biofluids) containing insulin (5 µg/mL),
hydrocortisone (70 ng/mL), epidermal
growth factor (25 ng/mL), triiodothyronine
(6.5 ng/mL), bovine pituitary extract (10
µg/mL), retinoic acid (0.1 ng/mL), bovine
serum albumin (0.5 mg/mL), transferrin (10
µg/mL), penicillin (100 U/mL), strepto-
mycin (100 µg/mL), gentamicin (50
µg/mL), and amphotericin B (50 ng/mL),
above (200 µL) and below (400 µL) the
cells. When cultures were confluent, we
removed amphotericin B and gentamicin
from the medium and maintained the cul-
tures for 1–4 days before study, with the api-
cal surfaces free of medium. In some
instances, we expanded HNE cell numbers
through additional passage(s) before use; we
used no cells beyond passage 3. To conﬁrm
the epithelial cell composition of the primary
cultures, we stained cells using a monoclonal
mouse antibody against human epithelial-
specific antigen (NCL-ESA; Vector
Laboratories, Burlingame, CA) and mouse
immunoglobulin G1 (IgG1) as control. We
visualized the presence of antigen on the cell
surfaces using a Vectastain ABC kit (Vector
Laboratories) with diaminobenzidine tetrahy-
drochloride (DAB) as a substrate followed by
counterstaining with hematoxylin. Similarly
stained cells of the WI-38 fibroblast line
served as negative controls.
Rhinovirus. We obtained RV16,
expanded by infection of WI-38 cells
(ATCC), from David Proud at Johns
Hopkins Asthma and Allergy Center. This
virus stock was previously shown to induce
cytokine production by upper and lower res-
piratory epithelial cells through mechanisms
that were RV16 specific and not associated
with factors coisolated with the virus (20).
We puriﬁed the virus stock by centrifugation
through sucrose gradients. To determine a
relative value for the viral dose of this stock
required to produce 50% infection of
BEAS-2B cells in culture (TCID50) in our
hands, we infected BEAS-2B cells grown to
conﬂuence in 24-well culture inserts in eight
replicates with 100 µL of log dilutions of the
stock virus for 1 hr. We then washed cultures
free of unbound virus and incubated them at
34°C for 72 hr. We diluted supernatant from
each of the freeze-thaw–lysed cultures 1:1 in
WI-38 medium and transferred them in
duplicate to cultures of WI-38 cells in 96-
well plates. After incubation at 34°C for 5
days, we determined the presence of viral
infection at each viral dilution by standard
cytopathic assay. This determination indi-
cated that 100 µL of the stock viral prepara-
tion, when diluted 1:10,000, produced 50%
infection of BEAS-2B cells in culture
(TCID50). We used this stock in all experi-
ments. Unless indicated otherwise, we inocu-
lated cells with a 1:1,000 dilution of the
stock preparation (i.e., 101 TCID50).
Oxidant exposure system. We randomly
assigned confluent epithelial cell cultures
grown at the air–liquid interface to groups
for a single exposure to air (5% CO2 in air)
as control or to the oxidants NO2 (2.0 ppm)
or O3 (0.2 ppm) for 3 hr. We bled nitrogen
dioxide through a metering system into one
of two matched 6-L Plexiglas exposure cham-
bers, each of which received a flow of 5%
CO2 in air at a rate of 1 L/min. Before this
mixing, we saturated the 5% CO2 in air with
water at 40°C to allow the air entering the
chamber to achieve > 97% relative humidity
at 37°C, despite the addition of the dry
NO2. We monitored the concentration of
NO2 in the chamber continuously with an
Interscan monitor and manually adjusted the
gas mixture to achieve and maintain the
desired concentration. We generated ozone
by directing 5% CO2 in air through a spe-
cially fabricated O3 generator consisting of a
glass and stainless steel cylinder containing
ultraviolet mercury vapor lamps. An O3
ultraviolet photometer (model 1008AH;
Dasibi, Glendale, CA), modiﬁed by Dasibi to
operate at a 200 mL/min ﬂow rate, provided
continuous measurement of O3 concentra-
tion within the chamber. We sent these
values to a computer that used an algorithm
to monitor changes in O3 concentration and
to operate a servo-controlled mechanism that
regulated the proportion of the total airﬂow
to the chamber that ﬁrst passed through the
generator. This system rapidly established
and consistently maintained the concentra-
tion of O3 at the desired level throughout the
exposure period. We maintained the relative
humidity of the inﬂow air and air within the
matched exposure chambers at > 97% and
the temperature at 37°C.
Infection/exposure protocol. We inocu-
lated confluent cultures of BEAS-2B or
HNE cells, acclimated to an air interface at
their apical surfaces, with RV16 diluted in
Hank’s balanced salt solution (HBSS). We
pipetted the inoculum or HBSS without
virus (control) onto the apical surface of each
culture. After 1 hr at 34°C, we removed the
apical solution and removed the unbound
virus by gentle washing with HBSS. We
then transferred the cells to the exposure
chambers to undergo oxidant or control air
exposure for up to 3 hr at 37°C. At the end
of exposure, we added medium to the apical
surfaces of the cells and returned the cultures
to the 34°C incubator, where they remained
while we took the required samples of
medium and/or cells, as described for the
individual experiments.
Preliminary dose–response experiments
for NO2 and O3 indicated that 3-hr expo-
sures to concentrations from 1.0 to 3.0 ppm
and 0.1 to 0.3 ppm, respectively, induced
cytokine release from bronchial epithelial
cells in a dose-dependent manner with mini-
mal effect on cell viability. For the present
study, we used mid-range concentrations of
both oxidant gases to facilitate the detection
of additive or synergistic interactions with
virus infection.
Measurements of IL-8 and ICAM-1. We
pooled equal volumes of medium from above
and below each culture for assay of IL-8 pro-
tein. We determined the concentration of
human IL-8 in culture medium using a com-
mercially available ELISA kit (Biosource,
Camarillo, CA). The reported level of sensi-
tivity for this assay is < 10 pg/mL, with a lin-
ear range of detection between 15.6 and
1,000 pg/mL. All samples fell, or we diluted
them to fall, within this range. The antibody
is reported by the manufacturer (Biosource)
not to cross-react with IL-1β, IL-2, IL-3,
IL-4, IL-7, IL-10, IL-13, IFNγ, TNFα, or
TNFβ. Because neither exposure to the oxi-
dants nor infection with virus at the concen-
trations employed affected cell number or
viability, we report IL-8 release as picograms
per milliliter medium. We determined the
expression of ICAM-1 on the surfaces of
cells in culture using a double-antibody col-
orimetric detection assay developed in our
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tures free of medium with phosphate-
buffered saline (PBS) and fixed them with
2% paraformaldehyde in PBS for 10 min at
room temperature (RT). We again washed
the ﬁxed cultures and incubated them with
5% normal goat serum (NGS; Kirkegaard
and Perry Labs, Gaithersburg, MD) in PBS
for 1 hr at 37°C. After washing, we incu-
bated cultures with mouse anti-CD54 anti-
body (1 µg/mL; Immunotech, Westbrook,
ME) for 45 min at RT or overnight at 4°C.
After washing the cultures with 0.05%
Tween 20 in PBS, we incubated them with
goat anti-mouse IgG–horseradish peroxidase
(1:5,000; American Qualex, San Clemente,
CA) in 5% NGS in PBS for 45 min at RT.
After a ﬁnal wash with 0.05% Tween 20 in
PBS, we added 3,3´,5,5´-tetramethylbenzi-
dine (TMB) substrate (Kirkegaard and
Perry) and allowed the color to develop. We
stopped the reaction at 20 min with 0.18 M
sulfuric acid and read the absorbance at 450
nm. We report ICAM-1 expression as the
percentage increase in expression in treated
cells above that in air-exposed, noninfected
control cultures.
Statistical analyses. We present data as
means ± SE. We tested differences between
means for group data for signiﬁcance by the
nonpaired Student’s t-test, and used one-way
repeated-measures analysis of variance for
comparing cytokine release kinetics. We per-
formed statistical analyses with SigmaStat
Statistical software (Jandel Scientific, San
Rafael, CA), and considered p-values < 0.05
signiﬁcant.
Results
Characteristics of IL-8 release from BEAS-2B
cells. Figure 1A shows the effect of RV16
infection and NO2 exposure (2.0 ppm),
alone or in combination, on the release of
IL-8, in excess of that released from control
cells. The combined treatment induced
marked enhancement of cytokine release
above the levels predicted from the modest
stimulating effects of the individual treat-
ments. Increases above the predicted additive
effects were 42%, 191%, and 250% at the
1:3,000, 1:1,000, and 1:300 dilutions of
RV, respectively. In response to control con-
ditions (sham inoculation and air exposure),
37 ± 4 pg/mL of IL-8 was released into the
medium. Exposure to O3 (0.2 ppm), a more
highly reactive oxidant, produced a similar
enhancement of the RV16-induced release
of IL-8 (Figure 1B). This effect was less pro-
nounced than that seen with NO2, however,
resulting in 67%, 44%, and 41% increases
above the additive effects at the three dilu-
tions of virus, respectively. Release of IL-8
from cells exposed to control conditions was
65 ± 5 pg/mL.
The release of IL-8 from the cells
occurred rapidly in response to each of the
stimuli and followed a similar time course.
Figure 2 compares the patterns of release in
response to virus and NO2, singly and in
combination. We achieved maximal release
under conditions of individual stimulation
within 6 hr from the end of the 3-hr expo-
sure period (i.e., 9 hr from the end of the 1-
hr inoculation period). This time course was
not altered by combined stimulation of the
cells by virus and oxidant. When expressed
as IL-8 released in response to each experi-
mental condition in excess of that under the
control condition, the release at the 6-hr and
12-hr time points in response to combined
infection and NO2 exposure was signiﬁcantly
higher than the sum of release from the cells
that underwent only infection or only NO2
exposure. These data conﬁrm, at earlier time
points, the synergism between RV16 and
NO2 observed at 18 hr postexposure in sepa-
rate experiments and depicted in Figure 1A.
Further, they demonstrate the consistency of
the synergistic enhancement of RV16-
induced inﬂammation by oxidant stimuli.
Responses of HNE cells. HNE cells repre-
sent the principal upper respiratory cell in
which interactions between RV16 and oxi-
dant pollutants would occur under normal
conditions in vivo. To confirm that the
responses observed in cells of the BEAS-2B
line reflected those of primary cells, we
examined the release of IL-8 from HNE cells
in response to RV16 infection in the pres-
ence and absence of subsequent exposure to
NO2 or O3. Table 1 summarizes these data.
Release of the cytokine from control cells
during the 18 hr posttreatment period was
approximately 3,000 times higher in primary
cells compared with BEAS-2B cells (~15
ng/mL vs. ~50 pg/mL, respectively).
Inoculation of the cultures with a minimally
infective concentration of RV16 (i.e., 101
TCID50) produced small increases in IL-8
release in the primary cells that, on average,
did not reach statistical significance.
Nevertheless, when combined with NO2
exposure (2.0 ppm), the low level of this
infective stimulus signiﬁcantly enhanced the
response. The level of release of IL-8 by HNE
cells after combined RV16 and NO2 exposure
was signiﬁcantly greater than the sum of the
individual responses (Table 1). Similarly, the
combination of RV16 infection and exposure
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Figure 1. Release of IL-8 by BEAS-2B cells into the medium, in excess of that released by air-exposed and
sham-inoculated cells, during an 18-hr period after the end of the exposure period. We added fresh
medium above and below the cells at the end of the exposure period and returned the cultures to the 34°C
incubator. We pooled and assayed equal volumes of medium from the apical and basal chambers. (A)
Cultures exposed to air or NO2 (2.0 ppm, 3 hr); data from two experiments with three cultures per treat-
ment group. (B) Cultures exposed to air or O3 (0.2 ppm, 3 hr); data from four experiments with three cul-
tures per treatment group. Dotted lines indicate the value corresponding to the numerical sum of the
individual oxidant and RV16 responses. Values represent concentration mean ± SE for each condition
above that released from sham-infected, air-exposed (control) cultures; n indicates the number of cul-
tures for each treatment group.
Figure 2. Kinetics of IL-8 release by BEAS-2B cells
in response to RV16 (1:1,000) with and without NO2
exposure (2.0 ppm). After adding fresh medium
above and below the cells at the end of the expo-
sure period, we returned the cultures to the 34°C
incubator. At the indicated times, we pooled and
assayed equal volumes of medium from the apical
and basal chambers. Values represent the amount
of protein (mean ± SE) cumulatively released into
the medium up to each time point; n indicates the
total number of cultures for each condition from
two separate experiments.
*p < 0.05 by repeated measures ANOVA in comparison
with corresponding air value. **Signiﬁcant difference (p <
0.05) by group t-test compared with the numerical sum of
individual responses to RV16 and NO2 at each time point
after those values are normalized to the sham-infected,
air-exposed controls at the corresponding time points.
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* **to O3 (0.2 ppm) enhanced cytokine release
signiﬁcantly more than the sum of the indi-
vidual RV16 and O3 stimuli. These results are
consistent with a synergistic, rather than addi-
tive, interaction between RV16 and the two
oxidant gases, similar to the effect demon-
strated in the BEAS-2B cells (Figure 1).
To determine whether a positive interac-
tion between RV16 and NO2 activates other
proinﬂammatory cell proteins, we also deter-
mined expression of ICAM-1 on the apical
surfaces of infected and/or exposed HNE
cells. We grew and treated primary cultures
according to a protocol identical to that used
for the IL-8 experiments, and assessed
ICAM-1 expression 18 hr after the exposure
period. Table 2 summarizes the results of
two experiments. We observed substantial
expression of cell surface ICAM-1 by
unstimulated HNE cells in culture. Because
cell preparations varied in their responses to
stimulation by virus or NO2, the data from
the experiments are more meaningfully pre-
sented as percentage increases above control
cells for each set of cultures. However, the
pattern of increased ICAM-1 expression
shown in Table 2 mirrors that seen in pre-
liminary experiments in which we infected
cultures or exposed them to NO2 indepen-
dently. Baseline expression was increased to
a statistically signiﬁcant extent (p < 0.05) by
both virus and oxidant. The effects of RV16
and NO2 combined to enhance cell surface
expression to an extent that appeared on
average to be additive in primary cultures of
HNE cells.
Inhibition of oxidant-dependent path-
ways. To confirm the involvement of oxi-
dant-mediated stimulation in the synthesis of
IL-8 in response to treatments of BEAS-2B
cells with RV16, NO2, and O3, we treated
cultures with the antioxidant and reactive
oxidant scavenger N-acetylcysteine (NAC;
Sigma) in a range of concentrations for 30
min before inoculation and throughout the
subsequent exposure and 18-hr postexposure
incubation period. NAC inhibited cytokine
release in response to NO2 (1.0 ppm) and
O3 (0.1 ppm) exposures in a similar and
dose-dependent manner (Figure 3). RV16-
induced IL-8 release was also inhibited in a
dose-dependent manner by the antioxidant,
but to a lesser extent than were the two oxi-
dant gases. At a concentration of NAC that
produced maximal inhibition of the effects
of oxidant exposures (40 mM), the combine
effects of RV16 with each of the oxidants at
the higher concentrations used in the previ-
ous experiments were reduced to levels
equivalent to or below those observed in
nontreated, unexposed cells (Figure 3B).
Preliminary experiments indicated that,
when we adjusted treatment solutions to a
pH of 7.4, this relatively high concentration
of NAC had no effect on cell viability as
determined by trypan blue dye exclusion
(control, 93.8 ± 1.6%; NAC, 95.2 ± 0.5%).
It is possible that, in addition to its actions
as an intracellular antioxidant, NAC treat-
ment directly reduced the interaction of
NO2 and O3 with the cells or interfered
with viral infectivity through undetermined
mechanisms. Nevertheless, these data pro-
vide compelling evidence for the importance
of oxidant-related pathways in the release of
the cytokine by each of the stimuli. Under
conditions of combined infection/exposure
and of oxidant exposure alone, reduction of
oxidant stress within the cells by NAC treat-
ment inhibited IL-8 release to statistically
equivalent levels (NO2 + RV16 + NAC vs.
NO2 + NAC, 46.9 ± 5.4 pg/mL vs. 42.1 ±
4.6 pg/mL; O3 + RV16 + NAC vs. O3 +
NAC, 20.8 ± 2.4 pg/mL vs. 19.3 ± 4.0
pg/mL; all p > 0.05; not shown in Figure 3).
Discussion
As evidence more strongly supports the
direct action of rhinovirus in the lower air-
ways in triggering asthma exacerbations (21),
understanding the inﬂuence of environmen-
tal agents on this process that also target the
peripheral airways becomes increasingly
important. The present study demonstrates
that the activation of proinﬂammatory path-
ways within cells of both the upper and lower
airway epithelium induced by infection with
RV16 can be significantly enhanced when
the cells are also exposed to the common
environmental oxidant pollutants NO2 and
O3. We found the enhanced expression of
the neutrophil chemotactic factor IL-8 to be
more than additive, indicating a synergistic
interaction of the stimuli leading to cytokine
production. We also observed an interactive
effect of these stimuli on expression of
ICAM-1, a protein involved in a wide range
of inﬂammation-associated binding processes
at the epithelial surface, at a level that was at
least additive.
Interactions between distinct chemical
and/or biologic agents that enhance the
expression of mediators of the inﬂammatory
process are not unusual. Steady-state levels of
IL-8 mRNA in monocytes treated with
lipopolysaccharide (LPS) were shown to be
synergistically increased by preconditioning
the cells with oxidant stress (22), and expres-
sion of ICAM-1 on human bronchial epithe-
lial cells was more than additively increased by
combined stimulation with TNFα and IFNγ
(23). In the case of several cytokines, espe-
cially IL-8, increased gene expression has been
associated with the activity of at least two
transcription factors working cooperatively to
transactivate the gene, for example, nuclear
factor (NF)-κB and NF-IL-6, CCAAT/
enhancer binding protein (C/EBP), or activa-
tor protein (AP)-1 (16,19,24–26). Thus, the
diversity of signaling and activation pathways
within most cells provides ample opportunity
for signiﬁcantly amplifying the inﬂammatory
response in the presence of multiple stimuli.
In the present study, we saw synergistic
interaction between RV16 infection and
chemical oxidant exposure, two naturally
occurring environmental challenges to the
airway epithelium. The pathway shared by
these two stimuli likely involves the develop-
ment of oxidative stress within the epithelial
cells and the activation of oxidant-responsive
transcription factors. In our studies, treat-
ment of the cells with the antioxidant NAC
markedly reduced production of IL-8 in
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Table 1. Cumulative release of IL-8 (ng/mL) from primary cultures of HNE cells in response to RV16 infec-
tion in the presence or absence of NO2 or O3 exposure during 18 hr after the exposure period.
RV16 Oxidant RV16 + oxidant
NO2 1.77 ± 0.75 6.21 ± 0.81* 13.00 ± 0.67 **
O3 1.13 ± 0.61 8.34 ± 0.64* 14.16 ± 0.75 **
NO2 data are from three separate experiments, each using cells from different tissue sources and containing ﬁve to six
cultures per treatment group; O3 data are from two separate experiments, each using cells from different tissue sources
and each containing ﬁve to six cultures per treatment group. Immediately following the 3-hr oxidant exposure period, we
added fresh medium to the culture inserts above and below the cells and returned the cultures to the 34°C incubator.
Then, after 18 hrs we pooled the medium from above and below the cells for assay of IL-8. Values represent mean ± SE of
cumulative release in excess of that seen in sham-infected and air-exposed (control) cultures. Control release: NO2,
18.59 ± 1.56 ng/mL; O3, 12.37 ± 1.13 ng/mL. 
*Significant (p < 0.05) increase in release above control values by group t-test. **Significant (p < 0.001) increase in
release compared with the numerical sum of individual RV16 and oxidanttreatments.
Table 2. Increased expression of ICAM-1 (%) on the apical surfaces of primary HNE cells in response to
RV16 infection and/or NO2 exposure 18 hr after the exposure period.
Tissue source RV16 NO2 RV16 + NO2
19 .5 ± 1.5* 14.4 ± 2.1* 31.1 ± 2.4*
2 13.5 ± 6.9 31.5 ± 4.7* 43.4 ± 7.1*
Data are from two separate experiments. Values represent individual mean ± SE of the percentage increase in expres-
sion in excess of that seen in sham-infected, air-exposed (control) cultures for each of the experiments. Six cultures per
treatment condition and control in each experiment, three from each of two different tissue sources. 
*Signiﬁcant (p < 0.01) increase in expression above control values within each experiment.response to RV16 alone and to NO2 and O3
alone or in combination with RV16.
Environmental pollutants with oxidant
properties, such as NO2 and O3, are well
known to exert their effects through the gen-
eration of oxidant stress within airway cells
(27), and reactive oxidant species are known
to play an especially central role in the regu-
lation of IL-8 production in these cells (28).
Furthermore, transcription factors such as
NF-κB, AP-1, and NF-IL-6 (19,24,29) are
known to mediate oxidant-related stimuli
leading to synthesis of IL-8, ICAM-1, and
other proinflammatory mediators (16,29).
In a study that assessed the effects of O3
exposure on IL-8 expression in cells of the
A549 type II line, electrophoretic mobility
shift assay indicated that binding of all three
of these factors, NF-κB, AP-1, and NF-IL-6,
to the IL-8 promoter accompanied increases
in IL-8 mRNA and protein levels (30).
The mechanisms through which RV16
infection stimulates IL-8 expression are less
clear. We know that attachment of members
of the major receptor group of rhinoviruses,
such as RV16, to their ICAM-1 receptors on
the epithelial cell surface is required for
increased IL-8 production (e.g., 13,31).
Furthermore, we have evidence that as much
as half of this stimulatory effect may be
related to the binding of the virus to the cell
surface (32). Our NAC data suggest that a
signiﬁcant portion of the effect on cytokine
release, whether related to binding or to
events involved with viral replication, is
associated with the generation of reactive
oxidant species within the cells.
Consistent with the results of in vivo stud-
ies in our laboratory (33) and many others,
we observed significant upregulation of
ICAM-1 in epithelial cells exposed to NO2
or O3. Increased cell surface expression of
ICAM-1 caused by RV16 infection has also
been reported previously (34,35), and in one
of two experiments we observed this in cells
that underwent RV16 infection alone. The
use of minimally infective concentrations of
RV16 in our studies likely accounts for the
inconsistency of these ICAM-1 data and is
also reflected in the lower levels of IL-8
released by the cells in our studies compared
with results of others. To increase the range
for potential synergistic interaction between
RV16 and the oxidants, we used concentra-
tions of virus (101 TCID50 per culture) that
are 1,000 times lower than those that have
been used to initiate maximal release of IL-8
in human airway epithelial cells (36).
Nevertheless, the time course of cytokine
release reported in the present studies is sim-
ilar to that observed with the higher virus
titers (36).
Although our data indicate that mecha-
nisms involving generation of reactive oxi-
dant species are likely to play a significant
role in the synergy of action between RV16
and NO2 or O3, the possibility exists that
some contribution could also come from
activation of a parallel nonoxidant pathway.
Such appears to be the case in the stimulation
of rat lung epithelial cells by TNFα and
H2O2 (37). In that study, in which these two
stimuli were shown to cooperate to activate
NF-κB, two separate pathways consisting of
different downstream effectors were indi-
cated to be involved. The incomplete inhibi-
tion of NO2-induced IL-8 release by NAC
in the present study suggests that the effects
of this pollutant may not be mediated solely
through oxidant-associated pathways.
We currently know little about the spe-
ciﬁc mechanisms through which NO2 stim-
ulates cytokine release; however, the
difference in oxidative capacity between
NO2 and the much stronger O3 could pro-
vide the basis for the activation of different
response elements by the two oxidants.
In summary, the present study demon-
strates that exposure of epithelial cells of the
upper and lower respiratory tract to the envi-
ronmental oxidant pollutants NO2 and O3
markedly enhances their RV16-induced
expression of proinflammatory activity.
Epithelium in both of these regions is a rec-
ognized common target of action for these
frequently occurring exposures under normal
conditions. Studies in children and adults
with asthma have shown RV16 to be the
most common viral precipitant of acute
attacks (5,6), and that lower airway inﬂam-
matory responses to the virus may play a
causal role in the triggering process (10). In
addition, earlier studies suggesting that rhi-
novirus infection increases the level of subse-
quent allergen-induced inflammation (38)
continue to find support in the results of
more recent investigations. However, we do
not presently know the extent to which
indoor and outdoor oxidant pollutants may
enhance these effects of rhinovirus in allergic
asthmatics. Carefully designed investigations
involving this subpopulation will be neces-
sary to determine if the interaction between
oxidant pollutants and rhinovirus infection
described in the present studies provides a
mechanism through which environmental
exposures may pose an important health risk
in these individuals.
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